We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Ritter Pharmaceuticals has partnered with the University of British Columbia (UBC)’s Michael Smith Laboratories in Canada to explore development of microbiome and RP-G28 in environmental enteropathy (EE).